SAN — Sanofi SA Cashflow Statement

0.000.00%

Last trade - 00:00

HealthcareBalancedLarge CapNeutral

Annual cashflow statement for Sanofi SA, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.

	2021 December 31st	2022 December 31st	C2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	ARS	ARS	ARS	ARS	PRESS
Standards:	IFRS	IFRS	IFRS	IFRS	—
Status:	Final	Final	Final	Final	Final
Net Income/Starting Line	6,223	8,371	5,400	5,560	—
Depreciation
Deferred Taxes
Non-Cash Items	-105	20	1,249	1,185	167
Discontinued Operations
Unusual Items
Equity in Net Earnings/Losses
Other Non-Cash Items
Changes in Working Capital	1,409	-707	413	-615	10,750
Change in Accounts Receivable
Change in Inventories
Change in Accounts Payable
Net Change in Other Assets & Liabilities
Other Operating Cash Flow
Cash from Operating Activities	10,522	10,526	10,258	8,914	10,917
Capital Expenditures	-2,043	-2,201	-2,906	-3,195	—
Purchase of Fixed Assets
Other Investing Cash Flow Items	-5,255	126	-3,294	-1,212	-2,447
Sale of Fixed Assets
Sale/Maturity of Investment
Change in Net Investments
Purchase of Investments
Other Investing Cash Flow
Cash from Investing Activities	-7,298	-2,075	-6,200	-4,407	-2,447
Financing Cash Flow Items	-48	-99	-63	-50	-8,207
Other Financing Cash Flow
Total Cash Dividends Paid
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities	-7,056	-5,821	-8,052	-5,763	-8,207
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash	-3,817	2,638	-4,026	-1,269	216